Neonatal jaundice is the most commonly treated medical condition in otherwise healthy newborns.1 To resolve the current debate within the medical community whether intervention is necessary,2 information pertaining to the benefits and risks of treatment is essential. Recent studies indicate that mothers consider jaundice a serious illness, thus increasing the risk of maternal behavior consistent with the vulnerable child syndrome.3,4 These studies suggest that treatment of jaundice may dramatically affect breast-feeding, leading to interruption in breast-feeding during therapy and premature weaning of the child.

Elander and Lindberg5 reported that a short period of separation between the mother and her newborn, as may occur with hospitalization and phototherapy, can decrease the duration of breast-feeding.

This content is only available via PDF.
You do not currently have access to this content.